06 Mar 2026 – Intimation towards update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption) amongst Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Ltd, Strides Pharma Services Private Limited and OneSource Specialty Pharma Limited and their respective shareholders
6th March 2026
Stock Exchange Intimation
05 Mar 2026 – Intimation about reaffirmation and withdrawal of credit ratings by CareEdge Ratings (CARE)
6th March 2026
Stock Exchange Intimation
04 Mar 2026: Intimation of Participation in Investec India Promoter & Founder Conference 2026, under Regulation 30 of SEBI (LODR) Regulations, 2015
4th March 2026
Stock Exchange Intimation
26 Feb 2026 – Intimation regarding receipt of No Objection / No Adverse Observation Letter from The National Stock Exchange of India Limited / BSE Limited in relation to the draft composite scheme of arrangement and amalgamation (merger by absorption)
26th February 2026
Stock Exchange Intimation
12 Feb 2026 – Intimation of ESG Rating by SES ESG Research Private Limited
12th February 2026
Stock Exchange Intimation
11 Feb 2026 – OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic in Saudi Arabia
11th February 2026
Stock Exchange Intimation
30 Jan 2026 – Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter ended December 31, 2025
30th January 2026
Stock Exchange Intimation
28 Jan 2026 – Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011 And Regulation 7(2) Of SEBI (PIT) Regulations, 2015